154 related articles for article (PubMed ID: 36717367)
21. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
Front Immunol; 2022; 13():956825. PubMed ID: 36177033
[TBL] [Abstract][Full Text] [Related]
22. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
[TBL] [Abstract][Full Text] [Related]
23. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
[TBL] [Abstract][Full Text] [Related]
24. The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.
Villanueva P; Wadia U; Crawford NW; Messina NL; Kollmann TR; Lucas M; Manning L; Richmond P; Pittet LF; Curtis N
PLoS One; 2022; 17(6):e0268042. PubMed ID: 35657850
[TBL] [Abstract][Full Text] [Related]
25. Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations.
Lee PP
Ann Acad Med Singap; 2015 Aug; 44(8):297-301. PubMed ID: 26477962
[TBL] [Abstract][Full Text] [Related]
26. Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis.
Shafiee A; Amini MJ; Arabzadeh Bahri R; Jafarabady K; Salehi SA; Hajishah H; Mozhgani SH
Eur J Med Res; 2023 Aug; 28(1):278. PubMed ID: 37559096
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM
Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739
[TBL] [Abstract][Full Text] [Related]
28. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19.
Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M
Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464
[TBL] [Abstract][Full Text] [Related]
29. DIAGNOSTIC VALUE OF THE REACTION AT THE BACILLUS CALMETTE-GUÉRIN VACCINATION SITE IN KAWASAKI DISEASE.
Diniz LMO; Castanheira RG; Giampietro YG; Silva MS; Nogueira FD; Pessoa PD; Santos TMDS; Coutinho GS; Romanelli RMC
Rev Paul Pediatr; 2021; 39():e2019338. PubMed ID: 32876305
[TBL] [Abstract][Full Text] [Related]
30. Erythema at the bacillus Calmette-Guerin scar after influenza vaccination.
Chavarri-Guerra Y; Soto-Perez-de-Celis E
Rev Soc Bras Med Trop; 2019; 53():e20190390. PubMed ID: 31859956
[No Abstract] [Full Text] [Related]
31. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.
Hause AM; Zhang B; Yue X; Marquez P; Myers TR; Parker C; Gee J; Su J; Shimabukuro TT; Shay DK
JAMA Netw Open; 2022 Jul; 5(7):e2222241. PubMed ID: 35838667
[TBL] [Abstract][Full Text] [Related]
32. The sensitivity of BCG scar as an indicator of previous vaccination among Sudanese infants.
Kheir AE; Alhaj AA; Ibrahim SA
Vaccine; 2011 Oct; 29(46):8189-91. PubMed ID: 21893144
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Bacillus Calmette-Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study.
Liao Q; Zheng Y; Wang Y; Ye L; Liu X; Jiao W; Liu Y; Zhu Y; Jia J; Sun L; Shen A; Wan C
Int J Infect Dis; 2022 Aug; 121():113-119. PubMed ID: 35429637
[TBL] [Abstract][Full Text] [Related]
34. Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.
Parmar K; Siddiqui A; Nugent K
Am J Med Sci; 2021 Jun; 361(6):683-689. PubMed ID: 33705721
[TBL] [Abstract][Full Text] [Related]
35. First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world.
Lu J; Zhang X; Xu H; Li Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2080443. PubMed ID: 35687363
[TBL] [Abstract][Full Text] [Related]
36. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
Hause AM; Marquez P; Zhang B; Su JR; Myers TR; Gee J; Panchanathan SS; Thompson D; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(2):39-43. PubMed ID: 36634021
[TBL] [Abstract][Full Text] [Related]
37. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.
Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA
JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973
[TBL] [Abstract][Full Text] [Related]
38. A global survey in the developmental landscape of possible vaccination strategies for COVID-19.
Gasmi A; Srinath S; Dadar M; Pivina L; Menzel A; Benahmed AG; Chirumbolo S; Bjørklund G
Clin Immunol; 2022 Apr; 237():108958. PubMed ID: 35218966
[TBL] [Abstract][Full Text] [Related]
39. Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience.
Oosterhuis I; Scholl J; van Puijenbroek E; Kant A; van Hunsel F
Drug Saf; 2023 Jan; 46(1):65-75. PubMed ID: 36350465
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of Bacille Calmette-Guerin vaccination policies in reducing infection and mortality of COVID-19: a systematic review.
Obnial JC; Suzuki M; Escuadra CJ; Austria JT; Ponce MJM; Cunanan E
Glob Health Res Policy; 2022 Nov; 7(1):42. PubMed ID: 36336688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
